Suspendu

Comparison of the RightSpot pH Indicator & RightLevel pH Detector With the Gold Standard of Radiographic Verification of Feeding Tube Placement & Gastrostomy Tube Replacement

0 critères remplis à partir de votre profilVoyez en un coup d'œil comment votre profil répond à chaque critère d'éligibilité.
Ce qui est collecté

Collecte de données

Données recueillies dès le début de l'étude - Prospective
Qui peut participer

À partir de 18 ans
+8 critères d'éligibilité
Voir tous les critères d'éligibilité
Comment se déroule l'étude

Cohorte

Suivi d'un groupe de personnes dans le temps pour mieux comprendre les causes et l'évolution d'une maladie.
Observationnel
Date de début : mars 2013
Voir le détail du protocole

Résumé

Sponsor principalSt. Louis University
Dernière mise à jour : 24 janvier 2017
Issu d'une base de données validée par les autorités. Revendiquer en tant que partenaire

Date de début de l'étude : 14 mars 2013

Date à laquelle le premier participant a commencé l'étude.

Feeding tube placement is a common procedure that occurs in most ICU healthcare settings. In addition, replacement of G-tubes is a common practice in most ED settings throughout the US. Various practices have been used to confirm its placement, including the usage of litmus paper (acid versus base only), pH level indicators (precise measurement), auscultation, bubbling method, aspirate appearance, chest radiography (CXR) and gastrografin . Review of data in numerous studies has revealed that many of these techniques may not provide fully accurate results, possibly leading to the potential for patient injuries, and even fatal complications. Auscultation, bubbling method, and aspirate appearance have been demonstrated to provide findings that can be misinterpreted and cause false assurance of correct placement. Several deaths and serious injuries have been attributed to the use of litmus paper in verification of feeding tube placement and subsequent utilization of the tube as well as G-tube replacement. Consequently, litmus paper is no longer considered to be a safe and effective confirmatory test for feeding tube placement or G-tube replacement. Currently, the gold standard for verification of feeding tube placement is CXR or abdominal x-ray and G-tube replacement in an acute care setting is abdominal x-ray with gastrografin. This method is time-consuming, costly, and results in an increase in patient exposure to radiation. In addition for a patient who resides outside of the hospital setting at the time of needed G-tube replacement there is additional costs of transport to and from the ED. An alternative to CXR is measurement of gastric content pH level. This is a confirmed and valid tool for nasogastric/orogastric (NG/OG) verification and a recognized replacement of the litmus paper test.A pH level of 4.5 or less has been validated to indicate presence of gastric contents. A drawback to the use of typical pH indicators alone is that they require fluid aspirate to be placed manually onto the indicator surface. This increases the risk of exposure to bodily fluids for medical personnel. Thus, the ideal device to determine accurate feeding tube placement and G-tube replacement is one that will precisely measure the acid (pH) level of aspirate and significantly reduce the risk of bodily fluid exposure. The RightSpot pH Indicator & RightLevel pH Detector are devices which purport to meet both of these criteria. Both can provide an accurate pH level. The pH paper is encased in a protective exterior that can be attached directly to a syringe, thus, decreasing the likelihood of accidental exposure. This study will evaluate the use of this novel device to accurately verify feeding tube placement in an ICU care setting and G-tube replacement (of foley catheter) by measuring the pH and comparing this with gastrografin radiographic confirmation. The G-tube (or foley catheter) will be placed by the treating physician, resident, mid-level provider or nurse as per policy and standard of care in the ICU or Emergency Department. Prior to x-ray confirmation of placement with gastrografin, the RightBio Metrics device will be placed on the tube as per manufacturer's instructions and stomach contents aspirated. The reading of the pH indicator and time it took to measure the pH will be recorded. The device will then be removed. Tube placement verification by x-ray will be done as per hospital protocol. The time of radiology reading of the x-ray will be documented. Procedures for feeding tube are similar, however two pH measurements will be obtained. The first measurement will be obtained with RightSpot pH Indicator at the time the tube is inserted into the stomach to measure gastric pH, and the second pH measurement will be obtained one hour later with RightLevel pH Detector to assess whether or not a pH change has occurred that suggests the tube has migrated into the small bowel. Radiographic confirmation will also be obtained at that time as it is the standard of care for feeding tube placements at SLU Hospital. Relevant aspects of subject's prior history will be recorded on a standardized data collection form (DCF). These include: Demographics Surgical history - when the G-tube was placed Current medications Any previous gastric bypass surgery or other GI surgery Use of acid-reducing medications in the past week (e.g. antacids, proton pump inhibitors, histamine antagonists) Relevant medical history (e.g. gastric ulcer, achlorhydria) Cost related information such as ambulance cost to and from ED, cost of x-ray for G-tube (or foley) replacement, cost of radiographic interpretation As this is a minimal risk device and the main endpoint is whether or not the device could determine placement of a feeding tube or G-tube, patients will not be followed beyond 24 hours.

Sponsor principalSt. Louis University
Dernière mise à jour : 24 janvier 2017
Issu d'une base de données validée par les autorités. Revendiquer en tant que partenaire

Protocole

Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.
Détails du design

11 participants à inclure

Nombre total de participants que l'essai clinique vise à recruter.

Cohorte

Ce type d'étude observe, sur une période définie, un groupe de personnes partageant une caractéristique commune (comme une maladie ou une année de naissance), afin d'analyser leur état de santé ou leur exposition à certains facteurs.

Éligibilité

Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.
Critères

Tout sexe

Le sexe biologique des participants éligibles à s'inscrire.

À partir de 18 ans

Tranche d'âge des participants éligibles à participer.

Volontaires sains non autorisés

Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.

Critères

4 critères d'inclusion nécessaires pour participer
Age older than 18

English proficiency of person providing informed consent

Patient or proxy able to provide informed consent

Requirement for placement of a feeding tube or a G-tube replacement

4 critères d'exclusion empêchent la participation
Grossly bloody aspirate

Inability to obtain consent

Patients that are younger than the age of 18

Pregnancy

Plan de l'étude

Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.
Objectifs de l'étude

Objectifs de l'étude

Objectifs principaux

Objectifs secondaires

Centres d'étude

Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.

Cette étude comporte 1 site

Saint Louis University Hospital

St Louis, United StatesOuvrir Saint Louis University Hospital dans Google Maps
Suspendu1 Centres d'Étude